Researchers have discovered a rare genetic mutation that can increase non-smokers' risk of developing lung cancer by 62 times. For smokers with this T790M mutation in the EGFR gene, the risk is elevated by 25 times compared to those without it. The mutation affects about one in 15,850 people and originated in Southern Appalachian populations around 200 to 225 years ago. While tobacco smoking remains the leading cause of lung cancer, this study highlights a significant genetic factor that can dramatically increase risk even for non-smokers.
Written locally by qwen2.5:14b on 2026-09-24,
using this article's own text rather than the other coverage of the
same event (that is the story summary below).
Smoking is a huge risk factor for lung cancer — but it’s not the only one.
asserted
it → ’ → cancer
Researchers have found an alarming trait that can skyrocket a person’s risk of developing this deadly disease.
asserted
that → find → disease
Surprisingly, it has nothing to do with cigarettes and everything to do with genetics.
asserted
it → have → genetics
According to a new study, a rare inherited germline mutation can increase lung cancer risk by 62 times in non-smokers.
uncertain
mutation → accord → smokers
Smokers with this mutation are 25 times more likely to develop the disease.
asserted
Smokers → develop → disease
Tobacco smoking, however, is still the leading cause of lung cancer.
asserted
smoking → lead → cancer
This unhealthy habit heightens lung cancer risk by four times in the general population.
asserted
habit → heighten → population
Even so, this study further shows that smokers are not the only ones susceptible to lung cancer — which is the second most common cancer in the US.
asserted
which → show → US
This dangerous disease is also the prime cause of cancer death in both men and women, according to the American Cancer Society.
uncertain
disease → accord → Society
Which mutation is increasing lung cancer risk?
asserted
mutation → increase → risk
As the study revealed, the T790M mutation in the epidermal growth factor receptor (EGFR) gene is strongly related to lung cancer risk.
asserted
mutation → reveal → risk
EGFR is a protein that controls how cells grow and divide.
asserted
cells → control → ?
When mutated, this protein can cause cancer cells to expand and spread.
asserted
cells → mutate → ?
Researchers studied 23andMe genotyping data across 3.37 million people and found the mutation to be prevalent in one in 15,850 individuals.
asserted
mutation → study → individuals
Though 17 cancers and non-pulmonary conditions were evaluated, the T790M mutation only exhibited a significant association with lung cancer.
asserted
mutation → evaluate → cancer
The T790M mutation originated in Southern Appalachian populations in the US about 200 to 225 years ago, according to the study.
uncertain
mutation → originate → study
EGFR mutation-positive lung cancer accounts for around 10-15% of lung cancers in the US, with an increased occurrence in Asian populations, according to the American Lung Association.
uncertain
cancer → account → Association
How can lung cancer screening help?
asserted
screening → help → ?
As with any cancer, screening and early detection for lung cancer can reduce the risk of death and increase life expectancy
“At the moment, screening for lung cancer is based, essentially, solely on tobacco exposure,” Pasi Jänne, M.D., Ph.D., a lung cancer specialist at Dana-Farber Cancer Institute and corresponding author, told Fierce Biotech.
asserted
Jänne → reduce → Biotech
“Here we’ve identified a genetic component that is also a risk factor, and maybe these are individuals that would benefit from screening and early detection to identify cancers at an earlier early [sic] stage when they’re still potentially curable.”
asserted
they → identify → stage
Jänne also pointed out that the study does not paint the entire picture regarding the lifetime risk of developing lung cancer in people who have the T790M mutation.
asserted
who → point → mutation
Environmental factors may also play a role.
uncertain
factors → play → role
“There may be more nuances to the genetics of those individuals that modify the risk,” he added.
uncertain
he → modify → risk
“Even in the presence of this mutation or environmental exposures that modify the risk.”
asserted
that → modify → risk
Scientists have developed different therapies used to go after EGFR-mutated lung cancer, including AstraZeneca’s Tagrisso and Johnson & Johnson’s Rybrevant.
asserted
Scientists → develop → Tagrisso
Additionally, in August, BlossomHill announced a macrocyclic molecule that targets EGFR, called BH-30643, to compete with Tagrisso.
asserted
that → announce → Tagrisso
The Aporia
